Position in JNJ
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$11,893,414
-$814,287 QoQ
Shares Held
46,830
-9.9% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.13%
of 13F equity value
Holder Rank
#1,006
of 4,664 holders
Holding Since
Jun 2020
22 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Phoenix Financial Ltd. holds $174,300,668 across 10 Drug Manufacturers - General names. JNJ ranks #3 (6.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
97,019 | $116,367,508 | |
| 2 | ABBV |
AbbVie Inc.
|
47,441 | $11,938,053 | |
| 3 | JNJ |
Johnson & Johnson
This page
|
46,830 | $11,893,414 | |
| 4 | NVO |
Novo Nordisk A S
|
158,343 | $7,590,962 | |
| 5 | MRK |
Merck & Co., Inc.
|
52,551 | $6,752,803 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
114,254 | $6,583,314 | |
| 7 | PFE |
Pfizer Inc
|
253,976 | $6,115,741 | |
| 8 | AZN |
Astrazeneca PLC
|
19,365 | $3,671,991 |
All Filings in JNJ
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $11,893,414 | 46,830 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $12,707,701 | 51,987 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $11,425,916 | 55,211 | Shares | Sole | 2026-02-05 | |
| 2025-09-30 | $6,552,185 | 35,337 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $4,751,441 | 31,106 | Shares | Sole | 2025-07-30 | |
| 2025-03-31 | $4,485,639 | 27,048 | Shares | Sole | 2025-05-07 | |
| 2024-12-31 | $4,203,379 | 29,065 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $4,873,305 | 30,071 | Shares | Sole | 2024-11-05 | |
| 2024-06-30 | $7,920,410 | 54,190 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $7,684,078 | 48,575 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $5,502,513 | 35,106 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $5,595,318 | 35,925 | Shares | Sole | 2023-12-04 | |
| 2023-06-30 | $4,614,035 | 27,876 | Shares | Sole | 2023-08-07 | |
| 2023-03-31 | $5,089,890 | 32,838 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $4,347,356 | 24,610 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $5,105,816 | 31,255 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $5,135,186 | 28,929 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $5,062,220 | 28,563 | Shares | Sole | 2022-05-10 | |
| 2021-12-31 | $2,779,715 | 16,249 | Shares | Sole | 2022-02-07 | |
| 2021-09-30 | $818,643 | 5,069 | Shares | Sole | 2021-10-27 | |
| 2021-03-31 | $220,229 | 1,340 | Shares | Defined | 2021-05-10 | |
| 2020-06-30 | $763,761 | 5,431 | Shares | Defined | 2020-08-10 | |
| No filing history on record for this holder in this stock. | ||||||